Capstan Therapeutics is a private company focused on developing therapies for various diseases.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Next-gen IV-delivered CAR-T eliminates need for patient cell harvesting and manufacturing, enabling off-the-shelf cell therapy with dramatic efficacy in hematologic malignancies; potential to expand CAR-T beyond niche indications.